Paroxysmal Nocturnal Hemoglobinuria
📧 Sign up to get email alerts when something new happens for Paroxysmal Nocturnal Hemoglobinuria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria [Phase 3]
A Phase 3 clinical trial update for eculizumab in paroxysmal nocturnal hemoglobinuria shows the study status as completed.
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [Phase 1]
Phase 1 study assessing the safety of adding sargramostim (GM-CSF) to chemotherapy in patients with refractory myeloid cancers; the trial ha…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of combining levamisole with cyclosporine A in patients with paroxysmal noc…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) [Phase 2]
Phase 2 trial evaluating the safety and efficacy of combining levamisole with cyclosporine A in patients with paroxysmal nocturnal hemoglobi…
-
CLINICAL_TRIALS trial_result · 2010-09-01Clinical Trial Update: Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes
Completed clinical trial evaluating the level of CD59 on red and white blood cells in patients with paroxysmal nocturnal hemoglobinuria and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies [Phase 2]
A Phase 2 clinical trial from St. Jude evaluated haploidentical hematopoietic stem cell transplantation for treatment-refractory hematologic…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 3]
This document reports a Phase 3 clinical trial evaluating haploidentical hematopoietic stem cell transplantation in patients with hematologi…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 3]
A Phase 3 clinical trial evaluating stem cell transplantation for hematologic malignancies has completed. The study covered several conditio…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update on stem cell transplantation as immunotherapy for hematologic malignancies. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria [Phase 3]
This update notes the completion of a Phase 3 trial evaluating eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria
A completed NHLBI-sponsored clinical trial evaluating the transfer of GPI-linked proteins to transfused patients with paroxysmal nocturnal h…
-
CLINICAL_TRIALS trial_result · 2007-02-21Clinical Trial Update: Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab [Phase 3]
A Phase 3 trial evaluated the safety of eculizumab in patients with paroxysmal nocturnal hemoglobinuria. The study has completed.
-
CLINICAL_TRIALS trial_result · 2006-12-04Clinical Trial Update: Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients [Phase 3]
A Phase 3 study evaluating eculizumab in transfusion-dependent paroxysmal nocturnal hemoglobinuria has completed.